ProShare Advisors’s Immune Design Corp. IMDZ Stock Holding History

ProShare Advisors’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-13,828	Closed	-$105K	–	1783
2016 Q3	$105K	Sell	13,828 -2,544	-16%	-$18.6K	﹤0.01%	1413
2016 Q2	$134K	Buy	16,372 +185	+1%	+$2.31K	﹤0.01%	1494
2016 Q1	$210K	Sell	16,187 -1,661	-9%	-$19.2K	﹤0.01%	1397
2015 Q4	$358K	Buy	+17,848	New	+$308K	﹤0.01%	1205

Other funds holding IMDZ

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

PAI

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ProShare Advisors's IMDZ Position: Q4 2016 in Review

ProShare Advisors sold out of Immune Design Corp. (IMDZ) in Q4 2016, closing a stake of 13,828 shares — an estimated $105K sold.

ProShare Advisors first reported a position in IMDZ in Q4 2015 and held it in 4 quarters. The position peaked at $358K in Q4 2015. 65 funds tracked by Wall St. Rank hold IMDZ as of Q4 2016.

ProShare Advisors reported no remaining Immune Design Corp. position as of Q4 2016 after selling out during the quarter.
ProShare Advisors sold 13,828 Immune Design Corp. shares in Q4 2016, an estimated $105K.
ProShare Advisors first reported a position in Immune Design Corp. in Q4 2015 and held it in 4 quarters.
ProShare Advisors's Immune Design Corp. position peaked at $358K in Q4 2015.
65 funds tracked by Wall St. Rank held Immune Design Corp. as of Q4 2016.

Based on ProShare Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.